Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates—is postnatal age at start of treatment important?

References

• Bancalari E, Claure N, Gonzalez A. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 2005; 88: 192–201
   PubMedGoogle Scholar
• Noerr B. Current controversies in the understanding of necrotizing enterocolitis. Part 1. Adv Neonatal care 2003; 3: 107–120
   PubMedGoogle Scholar
• Knight D B. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001; 6: 63–73
   PubMedGoogle Scholar
• Clyman R I. Ibuprofen and patent ductus arteriosus. N Engl J Med 2000; 343: 728–730
   PubMed Web of Science ®Google Scholar
• Fanaroff A A, Hack M, Walsh M C. The NICHD neonatal research network: Changes in practice and outcomes during the first 15 years. Semin Perinatol 2003; 27: 281–287
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and low birth weight infants. Cochrane Database Syst Rev 2005, CD003481
   Google Scholar
• Christmann V, Leim K D, Semmekrot B A, Van de Bor M. Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin. Acta Paediatr 2002; 91: 369–370
   PubMedGoogle Scholar
• Leonhardt A, Strehl R, Barth H, Seyberth H W. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus. Acta Paediatr 2004; 93: 233–240
   PubMedGoogle Scholar
• Kalia Y N, Nonato L B, Luind C H, Guy R H. Development of skin barrier function in premature infants. J Invest Dermatol 1998; 111: 320–326
   PubMed Web of Science ®Google Scholar
• Greeley C, Snell J, Colaco A, Beatley J, Bailey J, Bjorn S I. Pediatric reference ranges for electrolytes and creatinine. Clinical Chemistry 1993; 39: 1172
   Google Scholar
• Skinner J. Diagnosis of patent ductus arteriosus. Semin Neonatol 2001; 6: 49–61
   PubMedGoogle Scholar
• Skinner J, Alverson D, Hunter S. Echocardiography for the neonatologist. 1st ed. Churchill Livingstone, London 2000
   Google Scholar
• Rutter N. Clinical consequences of an immature barrier. Semin Neonatol 2000; 5: 281–287
   PubMedGoogle Scholar
• Agren J, Sjors G, Sedin G. Transepidermal water loss in infants born at 24 weeks of gestation. Acta Paediatr 1998; 87: 1185–1190
   PubMed Web of Science ®Google Scholar
• Fanaroff A A, Wald M, Gruber H S, Klaus M H. Insensible water loss in low birth weight infants. Pediatrics 1972; 50: 236–245
   PubMed Web of Science ®Google Scholar
• Baumgart S, Engle W D, Fox W W, Polin R A. Radiant warmer power and body size as determinants of insensible water loss in the critically ill neonate. Pediatr Res 1981; 15: 1495–1499
   PubMedGoogle Scholar
• Rutter N. The hazards of an immature skin. Practical perinatal care—the baby under 1000 grams, D Harvey, R WI Cooke, G A Levitt. Butterworth and Co., London 1989; 99
   Google Scholar
• Lorenz J M, Kleinman L I, Kotagal U R, Reller M D. Water balance in very low birth weight infants: Relationship to water and sodium intake and effect on outcome. J Pediatr 1982; 101: 423–432
   PubMed Web of Science ®Google Scholar
• Dimitriou G, Kavvadia V, Marcow M, Greengough A. Antenatal steroids and fluid balance in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 2005; 90: F509–F513
   Google Scholar
• Zanardo V, Vedovato S, Lago P, Piva D, Faggian D, Chiozza L. Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus. Fetal Diagn Ther 2005; 20: 534–539
   PubMed Web of Science ®Google Scholar
• Aranda J V, Yaffe S J. Neonatal and pediatric pharmacology. Therapeutic principles in practice. 3rd ed. Lippincott Williams and Wilkins, London 2004; 672–676
   Google Scholar
• Walker M P, Moore T R, Brace R A. Indomethacin and arginine–vasopressin interaction in the fetal kidney: A mechanism of oliguria. Am J Obstet Gynecol 1994; 171: 1234–1241
   PubMed Web of Science ®Google Scholar
• Maston J R, Stokes J B, Robillard J E. Effects of inhibition of prostaglandin-synthesis on fetal renal function. Kidney Int 1981; 20: 621–627
   PubMedGoogle Scholar
• Cotton R B. Don't discard your indomethacin yet. Acta Pediatr 2000; 89: 1279
   Google Scholar
• Roberts L J, Morrow J D. Analgesic–antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. Goodman and Gilman's The pharmacological basis of therapeutics. 10th ed, J G Hardman, L E Limbard. McGraw-Hill, New York 2001; 695
   Google Scholar
• Chamama N S, Mosig D, Drukker A, Guingnard J P. The renal hemodynamic effects of ibuprofen in the newborn rabbit. Pediatr Res 2000; 48: 600–605
   PubMedGoogle Scholar